1-11 of 11
Jochen Utikal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Cell–Derived Angiopoietin-2 Promotes Metastasis in Melanoma

Ashik Ahmed Abdul Pari, Mahak Singhal, Corinne Hübers, Carolin Mogler, Benjamin Schieb, Anja Gampp, Nicolas Gengenbacher, Louise E. Reynolds, Dorothee Terhardt, Cyrill Géraud, Jochen Utikal, Markus Thomas, Sergij Goerdt, Kairbaan M. Hodivala-Dilke, Hellmut G. Augustin, Moritz Felcht
Journal: Cancer Research
Cancer Res (2020) 80 (12): 2586–2598.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-2660
Published: 15 June 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling

Viktor Fleming, Xiaoying Hu, Céline Weller, Rebekka Weber, Christopher Groth, Zeno Riester, Laura Hüser, Qian Sun, Vasyl Nagibin, Carsten Kirschning, Vincenzo Bronte, Jochen Utikal, Peter Altevogt, Viktor Umansky
Journal: Cancer Research
Cancer Res (2019) 79 (18): 4715–4728.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-0053
Published: 13 September 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 1274: Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to channel antagonists

Karol Granados, Laura Hüser, Aniello Federico, Sachindra Sachindra, Gretchen Wolff, Viktor Umansky, Jochen Utikal
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1274.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1274
Published: 01 July 2019
View article
Journal Articles

Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma

Robert A. Jabulowsky, Carmen Loquai, Heidrun Mitzel-Rink, Jochen Utikal, Christoffer Gebhardt, Jessica C. Hassel, Roland Kaufmann, Andreas Pinter, Evelyna Derhovanessian, Christine Anft, Sebastian Attig, Alexandra Deubel, Mustafa Diken, Maike Gold, Claudia Guertler, Heinrich Haas, Ludwig Heesen, Alexandra Kemmer-Brück, Lena M. Kranz, Klaus Kuehlcke, Andreas Kuhn, Peter Langguth, Ulrich Luxemburger, Daniel Maurus, Martin Meng, Felicitas Müller, Richard Rae, Fatih Sari, Katharina Schreeb, Doreen Schwarck-Kokarakis, Malte Stein, Dirk Jäger, Stephan Grabbe, Sebastian Kreiter, Christoph Huber, Özlem Türeci, Ugur Sahin
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT156.
DOI: https://doi.org/10.1158/1538-7445.AM2018-CT156
Published: 01 July 2018
View article
Journal Articles

CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions

Carolin Blattner, Viktor Fleming, Rebekka Weber, Bianca Himmelhan, Peter Altevogt, Christoffer Gebhardt, Torsten J. Schulze, Hila Razon, Elias Hawila, Gizi Wildbaum, Jochen Utikal, Nathan Karin, Viktor Umansky
Journal: Cancer Research
Cancer Res (2018) 78 (1): 157–167.
DOI: https://doi.org/10.1158/0008-5472.CAN-17-0348
Published: 02 January 2018
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy

Robert A. Jabulowsky, Carmen Loquai, Jochen Utikal, Jessica Hassel, Roland Kaufmann, Evelyna Derhovanessian, Mustafa Diken, Lena M. Kranz, Heinrich Haas, Sebastian Attig, Christine Anft, Janina Buck, Jan Diekmann, Daniel Fritz, Kerstin Hartmann, Alexandra Kemmer-Brueck, Klaus Kuehlcke, Andreas N. Kuhn, Peter Langguth, Ulrich Luxemburger, Martin Meng, Richard Rae, Fatih Sari, Doreen Schwarck-Kokarakis, Malte Stein, Stephan Grabbe, Sebastian Kreiter, Oezlem Tuereci, Christoph Huber, Ugur Sahin
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT034.
DOI: https://doi.org/10.1158/1538-7445.AM2017-CT034
Published: 01 July 2017
View article
Journal Articles

Abstract CT022: IVAC® MUTANOME - A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

Matthias Miller, Carmen Loquai, Björn-Philipp Kloke, Sebastian Attig, Nicole Bidmon, Stefanie Bolte, Valesca Bukur, Evelyna Derhovanessian, Jan Diekmann, Angela Filbry, Sandra Heesch, Christoph Hoeller, Klaus Kuehlcke, David Langer, Martin Loewer, Felicitas Mueller, Inga Ortseifer, Burkhard Otte, Anna Paruzynski, Richard Rae, Barbara Schroers, Christine Seck, Kristina Spiess, Arbel D. Tadmor, Isabel Vogler, Mathias Vormehr, Alexandra Kemmer-Brueck, Andreas N. Kuhn, Ulrich Luxemburger, Sebastian Kreiter, Jochen Utikal, Stephan Grabbe, Oezlem Tuereci, Ugur Sahin
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT022.
DOI: https://doi.org/10.1158/1538-7445.AM2016-CT022
Published: 15 July 2016
View article
Journal Articles

Abstract CT032: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma

Robert A. Jabulowsky, Carmen Loquai, Mustafa Diken, Lena M. Kranz, Heinrich Haas, Sebastian Attig, Nicole Bidmon, Janina Buck, Evelyna Derhovanessian, Jan Diekmann, Daniel Fritz, Veronika Jahndel, Alexandra Kemmer-Brueck, Klaus Kuehlcke, Andreas N. Kuhn, Peter Langguth, Ulrich Luxemburger, Martin Meng, Felicitas Mueller, Richard Rae, Fatih Sari, Doreen Schwarck-Kokarakis, Christine Seck, Kristina Spieß, Meike Witt, Jessica C. Hassel, Jochen Utikal, Roland Kaufmann, Sebastian Kreiter, Christoph Huber, Oezlem Tuereci, Ugur Sahin
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT032.
DOI: https://doi.org/10.1158/1538-7445.AM2016-CT032
Published: 15 July 2016
View article
Journal Articles

Abstract 1277: Neural crest-like gene FOXD1 plays a role in melanoma cell migration and invasion

Huizi Wu, Lionel Larribere, Kasia Weina, Nathalie Knappe, Christoffer Gebhardt, Viktor Umansky, Jochen Utikal
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1277.
DOI: https://doi.org/10.1158/1538-7445.AM2016-1277
Published: 15 July 2016
View article
Journal Articles

Abstract CT202: IVAC MUTANOME: Individualized vaccines for the treatment of cancer

Bjoern-Philipp Kloke, Cedrik M. Britten, Carmen Loquai, Martin Löwer, Sebastian Attig, Valesca Bukur, Nicole Bidmon, Evelyna Derhovanessian, Jan Diekmann, Mustafa Diken, Angela Filbry, Stephan Grabbe, Sandra Heesch, Christoph Hoeller, David Langer, Uli Luxemburger, Matthias Miller, Felicitas Mueller, Tina Mueller-Brenne, Inga Ortseifer, Burkhard Otte, Anna Paruzynski, Sebastian Petri, Richard Rae, Christine Seck, Kristina Spieß, Arbel D. Tadmor, Jochen Utikal, Klaus Kuehlke, John Castle, Alexandra Kemmer-Brueck, Isabel Vogler, Andreas N. Kuhn, Sebastian Kreiter, Oezlem Tuereci, Ugur Sahin
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): CT202.
DOI: https://doi.org/10.1158/1538-7445.AM2015-CT202
Published: 01 August 2015
View article
Journal Articles

Abstract 805: Subcellular distribution of RAGE affects its functions in melanoma growth and progression

Maike Reith, Wolf-Henning Gebhardt, Kathrin Tarnanidis, Nikolaus B. Wagner, Kristian Ikenberg, Coretta Kehrel, Jochen Utikal, Christoffer Gebhardt
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 805.
DOI: https://doi.org/10.1158/1538-7445.AM2015-805
Published: 01 August 2015
View article